Clinical trials
Atherosclerosis trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
76 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 3 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 5 |
| 2011 | 6 |
| 2012 | 10 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 6 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 6 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 38 |
| Recruiting | 13 |
| Unknown status | 13 |
| Active, not recruiting | 5 |
| Terminated | 4 |
| Withdrawn | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Korea University | 15 |
| Korea University Guro Hospital | 7 |
| Seoul National University Bundang Hospital | 6 |
| Yonsei University | 5 |
| Amgen | 3 |
| GlaxoSmithKline | 3 |
| Korea University Anam Hospital | 3 |
| Samsung Medical Center | 3 |
| Asan Medical Center | 2 |
| AstraZeneca | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atherosclerosis | 76 |
| Cardiovascular Diseases | 15 |
| Coronary Artery Disease | 14 |
| Diabetes Mellitus, Type 2 | 10 |
| Peripheral Arterial Disease | 8 |
| Dyslipidemias | 7 |
| Acute Coronary Syndrome | 5 |
| Metabolic Syndrome | 4 |
| Coronary Disease | 3 |
| Diabetes Mellitus | 3 |
Trials
Showing 51 to 75 of 76. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.